Download Mouth Care - Scottish Palliative Care Guidelines

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Transcript
Scottish Palliative Care Guidelines ‐ Mouth Care Mouth Care
Introduction
Mouth care is a frequently neglected but crucial aspect of palliative care in all settings. It maintains
self-esteem, comfort, and the person’s ability to communicate, socialise, and enjoy food and drinks.
Mouth care should be part of daily routine patient care and intervention should be instigated early
to prevent more serious problems and treatment complications.
Key principles
 Assess every patient
 Plan regular effective mouth care
 Confidence to refer
 Identify urgent referrals.
Assessment
All patients are at risk of oral problems and will benefit from planned regular mouth care,
particularly patients receiving chemotherapy or radiotherapy who will need careful monitoring both
pre- and post-treatment.
 Drug history is significant as numerous medications can affect the oral environment:
o opioids, diuretics and anticholinergics increase dry mouth
o steroids increase the risk of candidosis
o bisphosphonates increase the risk of osteonecrosis of the jaw. Ill-fitting dentures and
surgical intervention including tooth extraction increase this risk, highlighting the need for
preventative oral hygiene therapy.
 Ask patients on a daily basis if they are having problems
 Ensure privacy
 Remove dentures before examining the mouth or performing routine mouth care
 Use a torch to thoroughly examine the mouth
 Check the lining of the mouth is clean. If not, refer to dry/coated mouth care section of this
guideline.
 Avoid pain by lubricating cracked lips with a water-based product.
Practice Point: Previous applications of water-based lubricants should be gently removed before
replacing. Refer to dry/coated mouth care.
 Look for signs of dryness, coating, ulceration, infection or tooth decay. Assess for pain.
 Document findings accurately and assess daily or at each visit.
 Consider dental referral if oral symptoms or if it has been more than 1 year since the patient has
been examined by a dentist.
Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 1 of 6 Review Date: 31/05/2017 Scottish Palliative Care Guidelines ‐ Mouth Care Management1
All patients: 
Keep mouth and lips clean, moist and intact by removal of plaque and debris. Refer to dry/coated mouth care. 
Dentate patients Edentulous patients Maintain fluid intake with frequent, small drinks.  Apply † water‐based gel to dry lips after oral care.  Where possible reduce intake of sugary foods and drinks between meals (refer to ‘Anorexia/Cachexia guideline’). Note: additional oral care requirements as frequency of intake increases.  Natural teeth should be cleaned with fluoride toothpaste (at least 1350ppm) after every meal, but at least twice daily if tolerated. Practice point: Mechanical brushing of teeth and gums to remove plaque and debris is as important as application of toothpaste or chlorhexidine digluconate 1%w/w dental gel.  Patients should be encouraged to spit out excess toothpaste after brushing.  The mouth should not be rinsed with water after brushing.  Partial dentures should be removed and cleaned separately.  A dental hygienist or dentist should provide professional instruction and advice on oral hygiene for those with complex dental work.  Silk brushes can be used to perform oral daily care for patients with a painful mouth. 




Denture hygiene: 



Mouth care if receiving chemotherapy/ radiotherapy– key differences All dentures should be marked with the patient’s name. A denture fixative may provide relief from extensive movement of dentures. Dentures should be removed overnight and soaked in a suitable cleansing solution o Dilute sodium hypochlorite solution for plastic dentures. o Chlorhexidine gluconate solution for dentures with metal parts. o Rinse dentures thoroughly before replacing in the mouth. Remember to check that the lining of the mouth is clean. If necessary clean the oral mucosa: refer to dry/coated mouth care. Dentures should be checked for cracks, sharp edges and missing teeth daily. Dentures should be brushed at least once daily over a sink of water. Use of a personal toothbrush and running water are adequate for the physical cleaning of dentures. Dentures should be rinsed thoroughly after meals. Dentures should be left out of the mouth overnight and soaked. Refer to ‘Edentulous patients’ advice. 

See local cancer centre/cancer network policy. Patients may be advised to avoid antipyretic analgesics (paracetamol, aspirin) if at risk of neutropenia (can mask fever due to sepsis).  Patients receiving head and neck radiotherapy should avoid oil‐based products. Other specialist advice regarding oral care during radiotherapy may also be given by the cancer centre. Caphosol® is a supersaturated calcium phosphate mouthrinse approved for restricted use for the prevention of oral mucositis in patients undergoing radiotherapy for head and neck cancer, and for patients undergoing chemotherapy. Consultation with a haematologist or oncologist is required before prescription Oral Hygiene Care Table 1: Specific measures Version 1 May 2014
1
† Indicates this use is off licence Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 2 of 6 Review Date: 31/05/2017 Scottish Palliative Care Guidelines ‐ Mouth Care Dry/coated mouth care



Oral care should be provided at least four times daily. Some patients may need more frequent care.
Review medication.
Gently remove coatings, debris and plaque from soft tissues, lips and mucosa.
Practice point: Failing to gently remove dried secretions, debris and plaque gently can cause pain,
ulceration, bleeding and predispose to infection.
 Use damp gauze to gently soak coated areas.
 College tweezers, damp gauze or moistened silk toothbrushes can then be used to gently remove
coatings and debris.
 Maintain hydration. Cold, unsweetened drinks (such as sips of water) should be taken frequently
through the day.
 Saliva stimulation should be considered if patient able to comply
o sugar-free chewing gum.
 Saliva substitutes or oral gel if other measures insufficient. Refer to section 12.3.5 of British National
Formulary (BNF).
Practice point: Avoid Glandosane® in dentate patients (long term use of acidic product may demineralise
tooth enamel)
 Fluoride mouthwash (0.05%) can be used at a different time from brushing
 Prescription of high-fluoride toothpaste (2800ppm or 5000ppm sodium fluoride) should be considered
as dry mouth increases the risk of dental caries. See dental practitioners’ formulary of BNF.
 Refer to dentist for application of high fluoride varnish (22,600ppm sodium fluoride) for desensitisation
as well as caries prevention
Painful mouth care




Seek dental opinion.
Consider oral mucositis as a possible cause, particularly in patients receiving chemotherapy or
radiotherapy. Oral mucositis is a condition characterised by pain and inflammation of the mucous
membrane which may present as painful mouth ulceration affecting any or all intra-oral surfaces.
Analgesia: soluble paracetamol and/or aspirin used as a mouthwash provides no topical effect. Do not
advise patients to use this as a mouthwash. If systemic analgesia required, see Pain Management
guideline.
Chlorhexidine gluconate 0.2% mouthwash can be considered when pain limits other mouth care
methods.10ml used twice daily may be useful to inhibit plaque formation in patients unable to tolerate
other mouth care measures. Dilute 1:1 with water if it stings. Alcohol-free preparations are available.
Practice point: If patient is unable to rinse and expectorate or there is an aspiration risk, soak gauze in
chlorhexidine gluconate 0.2% mouthwash and gently wipe over coated surfaces, teeth and gums.
 Urgent dental referral is required if mouth ulceration present.
Practice point: Causes include: trauma (from sharp teeth), haematinic deficiency, viral infection (herpes
simplex), aphthous ulceration, oral malignancy and mucositis.
 Gelclair ® is a viscous gel specially formulated to aid in the management of lesions of the oral
mucosa. It forms a protective film that, by coating and sticking to the lining of the mouth and throat,
offers rapid and effective pain management.
Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 3 of 6 Review Date: 31/05/2017 Scottish Palliative Care Guidelines ‐ Mouth Care Practice point: The contents of one sachet should be diluted with 40ml of water and used as a
mouthwash. This should be repeated three times a day 1 hour before eating or drinking.
Management of oral infections
Fungal infections
The most common types are candidiasis, denture stomatitis and angular cheilitis.


Maintain oral hygiene by following advice. Refer to Oral hygiene care.
In many cases a systemic antifungal such as fluconazole (capsules or suspension) 50mg daily for 7 days
will be indicated (review and extend as necessary).
Practice point: Refer for dental opinion if no improvement in 7 day period.

Topical miconazole oral gel should be considered for treating angular cheilitis (soreness, redness and
fissures at corners of mouth). Apply 2.5ml topically four times daily retained near lesions before
swallowing. Continue use for 48 hours after lesions healed.
Practice point: Always check the BNF thoroughly for drug interactions before prescription of antifungal
medication. Of note, fluconazole and miconazole (including topical route) should be avoided in patients
prescribed warfarin or statins.
Practice point: Swab angles, tongue and anterior nares to investigate possible Staphylococcal infection.
If present, adjust treatment accordingly.
 In patients where the above treatment is contraindicated, nystatin oral suspension can be considered.
Prescribe 1ml four times daily after food. Rinse around mouth and hold in contact with affected areas
as long as possible. Continue use for 48 hours after lesions healed.
 If persistent symptoms refer to dentist.
Viral infections
Herpes simplex is the most common viral infection.



Treat infections inside the mouth with oral aciclovir: 200mg five times a day for at least 5 days (or until
healing is complete). Soluble preparations are available.
Higher doses of antiviral medication should be considered if the patient is immunocompromised - seek
advice.
Provide supportive therapy: encourage fluid intake, keep mouth moist, apply water-based lubricant,
antipyretic medication and analgesia.
Practice point: Viral infections are highly contagious. Strict adherence to infection control
measures is essential.
Excessive drooling



Problem is impaired swallowing of saliva rather than excessive saliva production – consider
physiotherapy assistance around positional change and/or speech and language therapy around
swallowing techniques.
Neurodegenerative disorders, such as motor neurone disease, Parkinson’s disease, multiple sclerosis.
Medication to manage this may exacerbate dry mouth
† hyoscine, † glycopyrronium
o


Seek dental opinion as mouth care regime may need modification.
Further helpful information can be found at A problem solving approach at www.mndscotland.org.uk
Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 4 of 6 Review Date: 31/05/2017 Scottish Palliative Care Guidelines ‐ Mouth Care Taste change





Maintenance of nutritional intake is essential.
Diet should be adapted to try new foods and drinks which are enjoyable and look good.
If minerals are lacking, supplements may be required.
See Advice on Diet and Eating for Cancer patients
Read Taste changes: how do I eat well with taste changes leaflet available from dietitians.
Practice point: If patients are prescribed food supplements and/or having frequent small food intake
over the day, there is an added mouth care responsibility.
Resources
Patient/carer advice points

Register with a dentist and visit regularly.

Smoking and alcohol can contribute to oral problems.
Patient resources
http://www.nhsinform.co.uk/palliativecare/symptomcontrol/mouthcare
References
Bensinger, W., Schubert, M., Ang, K.-K., Brizel, D., Brown, E., Eilers, J. G., Elting, L., Mittal, B. B., Schattner, M.
A., Spielberger, R., Treister, N. S. and Trotti, A. M., 3rd. 2008. NCCN Task Force Report. prevention and
management of mucositis in cancer care. Journal of the National Comprehensive Cancer Network, 6 Suppl
1(pp. S1-21; quiz S22-4.
Clarkson, J. E., Worthington, H. V. and Eden, T. O. B. 2009. Interventions for preventing oral candidiasis for
patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, (4).
Clarkson, J. E., Worthington, H. V., Furness, S., Mccabe, M., Khalid, T. and Meyer, S. 2010. Interventions for
treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic
Reviews, (8).
Davies A and Finlay I. 2005. Oral Care in Advanced Disease. Oxford; Oxford University Press.
Davies, A. and Hall, S. 2011. Salivary gland dysfunction (dry mouth) in patients with advanced cancer.
International Journal of Palliative Nursing, 17(10), pp. 477-482.
De Conno F, Martini C, Sbanotto A, Ripamonti C and Ventafridda V. 2010. Mouth care. In: Hanks G, Cherny
Ni, Christakis Na, Fallon M, Kaasa S and Portenoy, Rk (eds). Oxford Textbook of Palliative Medicine. 4th ed.
Oxford; Oxford University Press.
Furness, S., Worthington, H. V., Bryan, G., Birchenough, S. and Mcmillan, R. 2011. Interventions for the
management of dry mouth: topical therapies. Cochrane database of systematic reviews, (12).
Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 5 of 6 Review Date: 31/05/2017 Scottish Palliative Care Guidelines ‐ Mouth Care Glenny, A.-M., Fernandez Mauleffinch, L. M., Pavitt, S. and Walsh, T. 2009. Interventions for the prevention
and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database of
Systematic Reviews, (1).
Harris, D. J., Eilers, J., Harriman, A., Cashavelly, B. J. and Maxwell, C. 2008. Putting evidence into practice:
evidence-based interventions for the management of oral mucositis. Clinical Journal of Oncology Nursing,
12(1), pp. 141-52.
Jensen, S. B., Pedersen, A. M. L., Vissink, A., Andersen, E., Brown, C. G., Davies, A. N., Dutilh, J., Fulton, J. S.,
Jankovic, L., Lopes, N. N. F., Mello, A. L. S., Muniz, L. V., Murdoch-Kinch, C. A., Nair, R. G., Napenas, J. J.,
Nogueira-Rodrigues, A., Saunders, D., Stirling, B., Von Bultzingslowen, I., Weikel, D. S., Elting, L. S.,
Spijkervet, F. K. L. and Brennan, M. T. 2010. A systematic review of salivary gland hypofunction and
xerostomia induced by cancer therapies: Management strategies and economic impact. Supportive Care in
Cancer, 18(8), pp. 1061-1079.
Lalla, R. V., Latortue, M. C., Hong, C. H., Ariyawardana, A., D'amato-Palumbo, S., Fischer, D. J., Martof, A.,
Nicolatou-Galitis, O., Patton, L. L., Elting, L. S., Spijkervet, F. K. L. and Brennan, M. T. 2010. A systematic
review of oral fungal infections in patients receiving cancer therapy. Supportive Care in Cancer, 18(8), pp.
985-992.
Pienaar, E. D., Young, T. and Holmes, H. 2010. Interventions for the prevention and management of
oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane database of
systematic reviews, (11).
Quinn, B. 2013. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment
of oral mucositis in patients receiving high-dose cancer therapy: A review of current data. European Journal
of Cancer Care, 22(5), pp. 564-579.
Scottish Dental Clinical Effectiveness Programme (Sdcep). 2011. Drug Prescribing in Dentistry [Online].
Available: http://www.sdcep.org.uk/index.aspx?o=2334 [Accessed 2014 Apr 29].
Scottish Dental Clinical Effectiveness Programme (Sdcep). 2011. Oral Health Assessment & Review [Online].
Available: http://www.sdcep.org.uk/index.aspx?o=3079 [Accessed 2014 Apr 29].
Scottish Dental Clinical Effectiveness Programme (Sdcep). 2011. Oral Health Management of Patients
Prescribed Bisphosphonates [Online]. Available: http://www.sdcep.org.uk/index.aspx?o=3017 [Accessed
2014 Apr 29].
Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A. M., Littlewood, A., Mccabe, M. G., Meyer,
S. and Khalid, T. 2011. Interventions for preventing oral mucositis for patients with cancer receiving
treatment. Cochrane database of systematic reviews, (4).
Worthington, H. V., Clarkson, J. E., Khalid, T., Meyer, S. and Mccabe, M. 2010. Interventions for treating oral
candidiasis for patients with cancer receiving treatment. Cochrane database of systematic reviews, (7).
Copyright © 2014 NHS Scotland Issue Date: 31/05/2014 Page 6 of 6 Review Date: 31/05/2017 
Document related concepts
no text concepts found